nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—CYP1A1—liver cancer	0.866	1	CbGaD
Clobetasol propionate—Folliculitis—Sorafenib—liver cancer	0.00196	0.0631	CcSEcCtD
Clobetasol propionate—Secondary infection—Epirubicin—liver cancer	0.00155	0.0498	CcSEcCtD
Clobetasol propionate—Secondary infection—Doxorubicin—liver cancer	0.00144	0.0461	CcSEcCtD
Clobetasol propionate—Leukoderma—Epirubicin—liver cancer	0.00107	0.0345	CcSEcCtD
Clobetasol propionate—Leukoderma—Doxorubicin—liver cancer	0.000992	0.0319	CcSEcCtD
Clobetasol propionate—Pain in extremity—Sorafenib—liver cancer	0.000895	0.0288	CcSEcCtD
Clobetasol propionate—Dry skin—Sorafenib—liver cancer	0.000821	0.0264	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Epirubicin—liver cancer	0.000766	0.0246	CcSEcCtD
Clobetasol propionate—Eruption—Epirubicin—liver cancer	0.000741	0.0238	CcSEcCtD
Clobetasol propionate—Psoriasis—Epirubicin—liver cancer	0.000725	0.0233	CcSEcCtD
Clobetasol propionate—Folliculitis—Epirubicin—liver cancer	0.000725	0.0233	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Doxorubicin—liver cancer	0.000709	0.0228	CcSEcCtD
Clobetasol propionate—Eruption—Doxorubicin—liver cancer	0.000686	0.022	CcSEcCtD
Clobetasol propionate—Folliculitis—Doxorubicin—liver cancer	0.000671	0.0216	CcSEcCtD
Clobetasol propionate—Psoriasis—Doxorubicin—liver cancer	0.000671	0.0216	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Sorafenib—liver cancer	0.000609	0.0196	CcSEcCtD
Clobetasol propionate—Rash pustular—Epirubicin—liver cancer	0.000572	0.0184	CcSEcCtD
Clobetasol propionate—Glycosuria—Epirubicin—liver cancer	0.000563	0.0181	CcSEcCtD
Clobetasol propionate—Stinging—Epirubicin—liver cancer	0.000563	0.0181	CcSEcCtD
Clobetasol propionate—Alopecia—Sorafenib—liver cancer	0.000547	0.0176	CcSEcCtD
Clobetasol propionate—Erythema—Sorafenib—liver cancer	0.000539	0.0173	CcSEcCtD
Clobetasol propionate—Rash pustular—Doxorubicin—liver cancer	0.000529	0.017	CcSEcCtD
Clobetasol propionate—Glycosuria—Doxorubicin—liver cancer	0.000521	0.0167	CcSEcCtD
Clobetasol propionate—Stinging—Doxorubicin—liver cancer	0.000521	0.0167	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000456	0.0147	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Epirubicin—liver cancer	0.000451	0.0145	CcSEcCtD
Clobetasol propionate—Infection—Sorafenib—liver cancer	0.000437	0.0141	CcSEcCtD
Clobetasol propionate—Skin disorder—Sorafenib—liver cancer	0.000427	0.0137	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Doxorubicin—liver cancer	0.000417	0.0134	CcSEcCtD
Clobetasol propionate—Pain—Sorafenib—liver cancer	0.000376	0.0121	CcSEcCtD
Clobetasol propionate—Vascular purpura—Epirubicin—liver cancer	0.00037	0.0119	CcSEcCtD
Clobetasol propionate—Purpura—Epirubicin—liver cancer	0.000343	0.011	CcSEcCtD
Clobetasol propionate—Vascular purpura—Doxorubicin—liver cancer	0.000342	0.011	CcSEcCtD
Clobetasol propionate—Pain in extremity—Epirubicin—liver cancer	0.000331	0.0106	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Sorafenib—liver cancer	0.000324	0.0104	CcSEcCtD
Clobetasol propionate—Purpura—Doxorubicin—liver cancer	0.000318	0.0102	CcSEcCtD
Clobetasol propionate—Pruritus—Sorafenib—liver cancer	0.000311	0.01	CcSEcCtD
Clobetasol propionate—Pain in extremity—Doxorubicin—liver cancer	0.000306	0.00984	CcSEcCtD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTA1—liver cancer	0.000304	0.00294	CbGpPWpGaD
Clobetasol propionate—Dry skin—Epirubicin—liver cancer	0.000303	0.00975	CcSEcCtD
Clobetasol propionate—CYP1A2—Estrogen Receptor Pathway—STAT3—liver cancer	0.000301	0.00291	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—NAT2—liver cancer	0.0003	0.0029	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTA4—liver cancer	0.000296	0.00287	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—liver cancer	0.000293	0.00283	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTA4—liver cancer	0.000292	0.00283	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.00029	0.00281	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTA2—liver cancer	0.000289	0.00279	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—GGT1—liver cancer	0.000282	0.00273	CbGpPWpGaD
Clobetasol propionate—Dry skin—Doxorubicin—liver cancer	0.000281	0.00902	CcSEcCtD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTA1—liver cancer	0.000278	0.00269	CbGpPWpGaD
Clobetasol propionate—Rash—Sorafenib—liver cancer	0.000277	0.00892	CcSEcCtD
Clobetasol propionate—Dermatitis—Sorafenib—liver cancer	0.000277	0.00891	CcSEcCtD
Clobetasol propionate—Headache—Sorafenib—liver cancer	0.000276	0.00886	CcSEcCtD
Clobetasol propionate—CYP1A1—Biological oxidations—NAT2—liver cancer	0.000275	0.00266	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000275	0.00266	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—NAT2—liver cancer	0.000272	0.00263	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000266	0.00257	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of Androgen receptor activity—JUN—liver cancer	0.000264	0.00255	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000262	0.00254	CbGpPWpGaD
Clobetasol propionate—Hyperglycaemia—Epirubicin—liver cancer	0.000258	0.00829	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CDKN2A—liver cancer	0.00025	0.00242	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.000249	0.00241	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—liver cancer	0.000243	0.00235	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—HPGDS—liver cancer	0.00024	0.00232	CbGpPWpGaD
Clobetasol propionate—Hyperglycaemia—Doxorubicin—liver cancer	0.000239	0.00767	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.000238	0.00231	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Tryptophan metabolism—CYP1A1—liver cancer	0.000236	0.00228	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—liver cancer	0.000236	0.00228	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.000236	0.00228	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GPX3—liver cancer	0.000231	0.00223	CbGpPWpGaD
Clobetasol propionate—Hypoaesthesia—Epirubicin—liver cancer	0.000228	0.00732	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000228	0.0022	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000227	0.0022	CbGpPWpGaD
Clobetasol propionate—Oedema peripheral—Epirubicin—liver cancer	0.000226	0.00725	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Epirubicin—liver cancer	0.000225	0.00723	CcSEcCtD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—NR1H4—liver cancer	0.000224	0.00216	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CDKN1B—liver cancer	0.000222	0.00214	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000221	0.00214	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—HPGDS—liver cancer	0.00022	0.00213	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—NR1I3—liver cancer	0.00022	0.00213	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—PPARA—liver cancer	0.000219	0.00212	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—IL2—liver cancer	0.000217	0.0021	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000215	0.00208	CbGpPWpGaD
Clobetasol propionate—NR3C1—Endoderm Differentiation—CTNNB1—liver cancer	0.000214	0.00207	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CCND1—liver cancer	0.000211	0.00205	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—JUN—liver cancer	0.000211	0.00204	CbGpPWpGaD
Clobetasol propionate—Hypoaesthesia—Doxorubicin—liver cancer	0.000211	0.00677	CcSEcCtD
Clobetasol propionate—CYP1A2—Biological oxidations—NR1H4—liver cancer	0.00021	0.00203	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CTNNB1—liver cancer	0.000209	0.00203	CbGpPWpGaD
Clobetasol propionate—Oedema peripheral—Doxorubicin—liver cancer	0.000209	0.00671	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000209	0.00202	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000209	0.00202	CbGpPWpGaD
Clobetasol propionate—Connective tissue disorder—Doxorubicin—liver cancer	0.000208	0.00669	CcSEcCtD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTA3—liver cancer	0.000206	0.002	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—MMP9—liver cancer	0.000205	0.00199	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000204	0.00197	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTA3—liver cancer	0.000204	0.00197	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000204	0.00197	CbGpPWpGaD
Clobetasol propionate—Alopecia—Epirubicin—liver cancer	0.000202	0.0065	CcSEcCtD
Clobetasol propionate—Erythema—Epirubicin—liver cancer	0.000199	0.0064	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000199	0.00192	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.000196	0.00189	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000192	0.00186	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—IL2—liver cancer	0.000191	0.00185	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000191	0.00185	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTA4—liver cancer	0.000189	0.00183	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000188	0.00182	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.000188	0.00182	CbGpPWpGaD
Clobetasol propionate—Alopecia—Doxorubicin—liver cancer	0.000187	0.00602	CcSEcCtD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTA4—liver cancer	0.000186	0.0018	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—JUN—liver cancer	0.000186	0.0018	CbGpPWpGaD
Clobetasol propionate—Erythema—Doxorubicin—liver cancer	0.000184	0.00593	CcSEcCtD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTA2—liver cancer	0.000184	0.00178	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.000182	0.00176	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—PPARG—liver cancer	0.000181	0.00175	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—liver cancer	0.00018	0.00174	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GGT1—liver cancer	0.00018	0.00174	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—CYP2E1—liver cancer	0.000179	0.00174	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTA1—liver cancer	0.000178	0.00172	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—CYP2E1—liver cancer	0.000177	0.00171	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—liver cancer	0.000176	0.0017	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—NAT2—liver cancer	0.000176	0.0017	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000173	0.00168	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	0.000173	0.00168	CbGpPWpGaD
Clobetasol propionate—NR3C1—Endoderm Differentiation—TGFB1—liver cancer	0.000173	0.00168	CbGpPWpGaD
Clobetasol propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.000171	0.00165	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—MYC—liver cancer	0.00017	0.00164	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—TGFB1—liver cancer	0.000169	0.00164	CbGpPWpGaD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—PPARA—liver cancer	0.000169	0.00163	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000168	0.00541	CcSEcCtD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—liver cancer	0.000165	0.0016	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GGT1—liver cancer	0.000165	0.00159	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—SERPINE1—liver cancer	0.000163	0.00158	CbGpPWpGaD
Clobetasol propionate—Infection—Epirubicin—liver cancer	0.000162	0.00519	CcSEcCtD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTP1—liver cancer	0.000161	0.00156	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.00016	0.00154	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000159	0.00154	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Epirubicin—liver cancer	0.000158	0.00508	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000156	0.00501	CcSEcCtD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000155	0.0015	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—HNF4A—liver cancer	0.000152	0.00147	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000151	0.00146	CbGpPWpGaD
Clobetasol propionate—Infection—Doxorubicin—liver cancer	0.00015	0.0048	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000149	0.00144	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000149	0.00144	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTM1—liver cancer	0.000148	0.00143	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTP1—liver cancer	0.000148	0.00143	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000147	0.00143	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	0.000147	0.00142	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Doxorubicin—liver cancer	0.000146	0.0047	CcSEcCtD
Clobetasol propionate—Paraesthesia—Epirubicin—liver cancer	0.000146	0.00469	CcSEcCtD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTP1—liver cancer	0.000146	0.00141	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000145	0.0014	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—HPGDS—liver cancer	0.00014	0.00136	CbGpPWpGaD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—PPARG—liver cancer	0.000139	0.00135	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—TP53—liver cancer	0.000139	0.00135	CbGpPWpGaD
Clobetasol propionate—Pain—Epirubicin—liver cancer	0.000139	0.00447	CcSEcCtD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—liver cancer	0.000136	0.00132	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTM1—liver cancer	0.000136	0.00132	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—EXOSC2—liver cancer	0.000135	0.00131	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Doxorubicin—liver cancer	0.000135	0.00434	CcSEcCtD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTM1—liver cancer	0.000134	0.0013	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000133	0.00129	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000133	0.00129	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000131	0.00127	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.00013	0.00126	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00013	0.00126	CbGpPWpGaD
Clobetasol propionate—Pain—Doxorubicin—liver cancer	0.000129	0.00414	CcSEcCtD
Clobetasol propionate—NR3C1—Adipogenesis—CTNNB1—liver cancer	0.000128	0.00123	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—IL6—liver cancer	0.000127	0.00123	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000127	0.00122	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000126	0.00122	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000125	0.00121	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—CDKN1A—liver cancer	0.000125	0.00121	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000123	0.00119	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—liver cancer	0.000123	0.00119	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Epirubicin—liver cancer	0.00012	0.00385	CcSEcCtD
Clobetasol propionate—Pruritus—Epirubicin—liver cancer	0.000115	0.0037	CcSEcCtD
Clobetasol propionate—CYP1A2—Biological oxidations—CYP2E1—liver cancer	0.000114	0.00111	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000114	0.00111	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—liver cancer	0.000114	0.0011	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	0.000113	0.00109	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—IL6—liver cancer	0.000112	0.00109	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—STAT3—liver cancer	0.000111	0.00108	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000111	0.00108	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Doxorubicin—liver cancer	0.000111	0.00356	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000111	0.00107	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.00011	0.00107	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—NR1H4—liver cancer	0.000108	0.00104	CbGpPWpGaD
Clobetasol propionate—Pruritus—Doxorubicin—liver cancer	0.000106	0.00342	CcSEcCtD
Clobetasol propionate—NR3C1—Gene Expression—NR1I3—liver cancer	0.000106	0.00102	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GGT1—liver cancer	0.000105	0.00102	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000105	0.00101	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—liver cancer	0.000104	0.001	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—TGFB1—liver cancer	0.000103	0.000997	CbGpPWpGaD
Clobetasol propionate—Rash—Epirubicin—liver cancer	0.000103	0.0033	CcSEcCtD
Clobetasol propionate—Dermatitis—Epirubicin—liver cancer	0.000102	0.00329	CcSEcCtD
Clobetasol propionate—Headache—Epirubicin—liver cancer	0.000102	0.00327	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000102	0.000985	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000102	0.000982	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—liver cancer	9.71e-05	0.000939	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	9.67e-05	0.000936	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—UGDH—liver cancer	9.64e-05	0.000933	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—TNF—liver cancer	9.63e-05	0.000931	CbGpPWpGaD
Clobetasol propionate—Rash—Doxorubicin—liver cancer	9.49e-05	0.00305	CcSEcCtD
Clobetasol propionate—Dermatitis—Doxorubicin—liver cancer	9.48e-05	0.00305	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	9.48e-05	0.000917	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	9.48e-05	0.000917	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTP1—liver cancer	9.44e-05	0.000913	CbGpPWpGaD
Clobetasol propionate—Headache—Doxorubicin—liver cancer	9.43e-05	0.00303	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	9.4e-05	0.00091	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—liver cancer	9.4e-05	0.000909	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	9.31e-05	0.0009	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—EPT1—liver cancer	9.07e-05	0.000877	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTM1—liver cancer	8.67e-05	0.000839	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—TAT—liver cancer	8.59e-05	0.000831	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	8.55e-05	0.000827	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	8.45e-05	0.000818	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	8.36e-05	0.000809	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—TNF—liver cancer	8.32e-05	0.000805	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—CYP1A1—liver cancer	8.22e-05	0.000795	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	8.11e-05	0.000784	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	8.07e-05	0.00078	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—PPARA—liver cancer	8.01e-05	0.000775	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	7.99e-05	0.000773	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—IL6—liver cancer	7.77e-05	0.000752	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—HNF4A—liver cancer	7.34e-05	0.00071	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—ESR1—liver cancer	7.26e-05	0.000702	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	6.71e-05	0.00065	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	6.62e-05	0.00064	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PSMA4—liver cancer	6.42e-05	0.000621	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PSMD10—liver cancer	6.42e-05	0.000621	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	6.33e-05	0.000612	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	6.17e-05	0.000597	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—UGDH—liver cancer	6.15e-05	0.000595	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	5.96e-05	0.000577	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GLUL—liver cancer	5.84e-05	0.000565	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CPT1B—liver cancer	5.84e-05	0.000565	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—EPT1—liver cancer	5.78e-05	0.000559	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NR1H4—liver cancer	5.63e-05	0.000545	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTA3—liver cancer	5.54e-05	0.000536	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—TAT—liver cancer	5.48e-05	0.00053	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.39e-05	0.000521	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTA4—liver cancer	5.07e-05	0.00049	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTA2—liver cancer	4.94e-05	0.000478	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTA1—liver cancer	4.76e-05	0.000461	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NAT2—liver cancer	4.71e-05	0.000456	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.53e-05	0.000438	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ALDOB—liver cancer	4.51e-05	0.000437	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—H2AFX—liver cancer	4.33e-05	0.000419	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CRABP1—liver cancer	4.31e-05	0.000417	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.03e-05	0.00039	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.88e-05	0.000375	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PPARA—liver cancer	3.86e-05	0.000373	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—MYC—liver cancer	3.77e-05	0.000365	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—HPGDS—liver cancer	3.76e-05	0.000364	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.74e-05	0.000362	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GLUL—liver cancer	3.73e-05	0.00036	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CPT1B—liver cancer	3.73e-05	0.00036	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NR1H4—liver cancer	3.59e-05	0.000348	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—MAPK14—liver cancer	3.56e-05	0.000344	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTA3—liver cancer	3.53e-05	0.000342	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—ESR1—liver cancer	3.49e-05	0.000338	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.41e-05	0.00033	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.37e-05	0.000326	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PSMA4—liver cancer	3.36e-05	0.000325	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PSMD10—liver cancer	3.36e-05	0.000325	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GOT2—liver cancer	3.26e-05	0.000316	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTA4—liver cancer	3.23e-05	0.000312	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PPARG—liver cancer	3.19e-05	0.000308	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.16e-05	0.000305	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTA2—liver cancer	3.15e-05	0.000305	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CYP2E1—liver cancer	3.07e-05	0.000297	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTA1—liver cancer	3.04e-05	0.000294	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NAT2—liver cancer	3e-05	0.00029	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.97e-05	0.000287	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.89e-05	0.000279	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ALDOB—liver cancer	2.88e-05	0.000278	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CYCS—liver cancer	2.87e-05	0.000278	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—SERPINE1—liver cancer	2.87e-05	0.000278	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GGT1—liver cancer	2.82e-05	0.000273	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GOT1—liver cancer	2.82e-05	0.000273	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CRABP1—liver cancer	2.75e-05	0.000266	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTP1—liver cancer	2.53e-05	0.000245	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—HMOX1—liver cancer	2.5e-05	0.000241	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.47e-05	0.000239	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—HPGDS—liver cancer	2.4e-05	0.000232	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.39e-05	0.000231	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTM1—liver cancer	2.33e-05	0.000225	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.17e-05	0.00021	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.15e-05	0.000208	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PSMA4—liver cancer	2.14e-05	0.000207	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PSMD10—liver cancer	2.14e-05	0.000207	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GOT2—liver cancer	2.08e-05	0.000201	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—MTHFR—liver cancer	2.06e-05	0.000199	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PPARA—liver cancer	2.02e-05	0.000195	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP2E1—liver cancer	1.96e-05	0.000189	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.89e-05	0.000183	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYCS—liver cancer	1.83e-05	0.000177	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—MYC—liver cancer	1.82e-05	0.000176	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.81e-05	0.000175	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GOT1—liver cancer	1.8e-05	0.000174	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GGT1—liver cancer	1.8e-05	0.000174	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CG—liver cancer	1.73e-05	0.000167	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PPARG—liver cancer	1.67e-05	0.000161	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTP1—liver cancer	1.61e-05	0.000156	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—HMOX1—liver cancer	1.59e-05	0.000154	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CD—liver cancer	1.52e-05	0.000147	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ALB—liver cancer	1.5e-05	0.000145	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTM1—liver cancer	1.48e-05	0.000143	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP1A1—liver cancer	1.41e-05	0.000136	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CB—liver cancer	1.32e-05	0.000128	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—MTHFR—liver cancer	1.31e-05	0.000127	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PPARA—liver cancer	1.29e-05	0.000124	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—AKT1—liver cancer	1.26e-05	0.000122	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.15e-05	0.000112	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CG—liver cancer	1.1e-05	0.000107	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PPARG—liver cancer	1.06e-05	0.000103	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CD—liver cancer	9.68e-06	9.37e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ALB—liver cancer	9.56e-06	9.25e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CB—liver cancer	8.44e-06	8.16e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CA—liver cancer	8.07e-06	7.8e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—AKT1—liver cancer	6.59e-06	6.38e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CA—liver cancer	5.14e-06	4.98e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—AKT1—liver cancer	4.2e-06	4.07e-05	CbGpPWpGaD
